←
Loading live data…
PRICE
Loading…
REVENUE MIX
Total Revenue100%
COST
COGS15%
R&D + SG&A38%
Op Margin47%
FINANCIAL HEALTH
REVENUE
$6.2B
Growth
93%
Gross M.
85%
P/E
147.2
EV/EBITDA
0
Net M.
49%
FCF M.
35%
D/E
0
Op M.
47%
PLUG INTO YOUR DCF
Historical growth
32.6%
Analyst 5y growth
—
Forward P/E
75.7
PEG ratio
2.30
Trailing EPS
$1.20
Forward EPS
$2.30
🚩 RED FLAG SCANNER — 10-K RISK FACTORS, YEAR OVER YEAR
TAM
SIZE
—
CAGR
—
Market-size estimates aren't available for this stock right now — see Financial Health and Risk Assessment below for a fundamentals-based read instead.
RISK ASSESSMENT
HIGTrading above a mechanical base-case DCF estimate of $69.33 (default assumptions) — priced for continued strong execution.
LOWDebt/equity of 0.00 — conservative balance sheet.
MEDRevenue growing 93% YoY — the multiple depends on this pace continuing; deceleration is a real risk.
🐂 BULL
PLTR shows revenue grew +92.8% YoY, 47% operating margin, 38% ROE, a healthy 35% free cash flow margin — a business converting growth into real profit.
🐻 BEAR
At a P/E of 147.2, the stock is priced for continued execution — any deceleration in growth or margin compression would likely pressure the multiple.
AI-powered data, computed by TreasureX · May contain inaccuracies
⚠️
All values, scores, and figures here are computed from your own assumptions and public data, for educational purposes only. This is not investment advice — TreasureX does not recommend buying or selling any security. Results change with your inputs. Please do your own research and use your own judgement before making any investment decision.